AstraZeneca PLC is 47.5x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($286.27 B vs $6.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTCT | AZN |
|---|---|---|
| Market cap | $6.03 B | $286.27 B |
| US-listed rank | #1262 | #45 |
| Revenue (latest FY) | $1.73B | - |
| Net income (latest FY) | $683.00M | - |
| Net margin | 39.5% | - |
| P/E (trailing FY) | 8.8 | - |
| SEC filings | 1,262 | 1,004 |
AstraZeneca PLC is 47.5x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($286.27 B vs $6.03 B).
Full pages: PTC THERAPEUTICS, INC. and AstraZeneca PLC, or browse the full rankings.